In this article, we will explore the importance of building translational assay cascades that prioritise human relevance and why it is crucial to bridge the gap between translational assays from lab to clinic

Ryan Mordue explores how modern tools and modalities let scientists succeed with “beyond Rule of 5” molecules (peptides, oligos, TACs), showing why rigid Ro5 filters no longer define drug-like space and how CatSci’s new Bioscience platform delivers the data to de-risk these complex therapeutics.